Rate My Professor David Reith

Associate Professor David Reith serves in the Dean's Department at the Dunedin School of Medicine, University of Otago, within the Faculty of Medicine and Division of Health Sciences. He holds academic qualifications including MB BS, MMedSc, PhD, DCH, DipRACOG, and FRACP. As Module Convenor for Clinical Pharmacology and Clinical Pharmacology Convenor for Health Sciences, Reith delivers teaching in clinical pharmacology, therapeutics, and prescribing. He also provides postgraduate teaching and supervision in clinical pharmacology. Additionally, he chairs the Editorial Advisory Board for the New Zealand Formulary and participates in medicines regulation and the promotion of quality use of medicines.

Reith's research specializations include clinical pharmacology, pharmacokinetics and pharmacodynamics using population pharmacokinetic modelling, pharmacoepidemiology and drug safety, medicines use in paediatric populations, and paediatric clinical pharmacology. His scholarly contributions feature highly cited publications such as 'Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit' (Nephrology Dialysis Transplantation, 2003), 'Updated guidelines for the management of paracetamol poisoning in Australia and New Zealand' (Medical Journal of Australia, 2020), 'Relative toxicity of beta blockers in overdose' (Journal of Toxicology: Clinical Toxicology, 1996), 'Repeated self-poisoning: increasing severity of self-harm as a predictor of subsequent suicide' (British Journal of Psychiatry, 2005), 'Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand' (Pediatric Drugs, 2009), 'Identification of priorities for medication safety in neonatal intensive care' (Drug Safety, 2005), and 'Acetaminophen causes an increased international normalized ratio by reducing functional factor VII' (Therapeutic Drug Monitoring, 2000). These works, often in collaboration with researchers from Australia and New Zealand, address toxicology, paediatric drug safety, adverse events, and medication management, reflecting his influence in pharmacoepidemiology and clinical toxicology.